Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.44 |
| ▸ | SPHK1 | Q9NYA1 | 11/20 | 0.42 |
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.37 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.37 |
| ▸ | SPHK2 | Q9NRA0 | 7/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4804721 | 1.00 | CYP2C9 (0.55) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL4804063 | 0.95 | CYP2C9 (0.59) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL1031532 | 0.95 | CYP2C9 (0.59) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL11468108 | 0.95 | CYP2C9 (0.59) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL2383177 | 0.91 | CYP2C9 (0.63) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL4796050 | 0.91 | CYP2C9 (0.63) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL9455138 | 0.90 | SPHK1 (0.47) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL9455144 | 0.90 | SPHK1 (0.47) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL7913835 | 0.90 | CYP2C9 (0.55) | CYP2C9ALDH1A1LMNAMAPTMEN1 | |
| SCHEMBL7913842 | 0.90 | CYP2C9 (0.55) | CYP2C9ALDH1A1LMNAMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 199 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113671068-A | Method for analyzing environmental pollutant targeting exposure component in blood plasma and application thereof | 暨南大学 | 2021-11-19 | — | — | CN | claimed |
| CN-113493629-A | Quantum dot ink and preparation method of quantum dot film | TCL科技集团股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| US-7335405-B2 | Nematic liquid crystal mixtures for use in bistable display devices | NEMOPTIC (FR) | 2008-02-26 | — | — | US | claimed |
| US-20060249708-A1 | Nematic liquid crystal mixtures for use in bistable display devices | CDC PROPRIETE INTELLECTUELLE (FR) | 2006-11-09 | — | — | US | claimed |
| US-20260040821-A1 | LAMINATE, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE COMPRISING THE LAMINATE | SAMSUNG ELECTRONICS CO LTD (KR) | 2026-02-05 | — | — | US | disclosed |
| EP-3469576-B1 | MULTI-LAYER DISPLAY WITH COLOR AND CONTRAST ENHANCEMENT | SAMSUNG ELECTRONICS CO LTD (KR) | 2024-07-03 | — | — | EP | disclosed |
| WO-2023054799-A2 | LIQUID CRYSTAL COMPOSITION, POLYMER-DISPERSED LIQUID CRYSTAL COMPOSITION CONTAINING SAME, AND ADVERTISEMENT SYSTEM | 이상섭 | 2023-04-06 | — | — | WO | disclosed |
| CN-113671068-B | Method for analyzing environmental pollutant targeted exposure group in blood plasma and application thereof | 暨南大学 | 2023-01-24 | — | — | CN | disclosed |
| CN-109478389-B | Multi-layer display with color and contrast enhancement | 三星电子株式会社 | 2023-01-10 | — | — | CN | disclosed |
| EP-2907864-B2 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING THIS COMPOSITION | DAINIPPON INK & CHEMICALS (JP) | 2022-05-18 | — | — | EP | disclosed |
| CN-109477972-B | Multi-layer high transparency display for light field generation | 三星电子株式会社 | 2022-02-22 | — | — | CN | disclosed |
| CN-113671068-A | Method for analyzing environmental pollutant targeting exposure component in blood plasma and application thereof | 暨南大学 | 2021-11-19 | — | — | CN | disclosed |
| EP-0118061-A2 | Liquid crystal guest host systems | MERCK PATENT GmbH (DE) | 1984-09-12 | — | — | EP | disclosed |
| EP-0104327-A2 | Use of cyclic derivatives as components of liquid cristals | MERCK PATENT GmbH (DE) | 1984-04-04 | — | — | EP | disclosed |
| US-4415470-A | HIGH SPEED SWITCHING | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-11-15 | — | — | US | disclosed |
| EP-0087056-A1 | Benzonitriles | MERCK PATENT GmbH (DE) | 1983-08-31 | — | — | EP | disclosed |
| EP-0074608-A2 | Liquid crystal halogen compounds, process for their preparation, dielectric and dectrooptical display element containing them | MERCK PATENT GmbH (DE) | 1983-03-23 | — | — | EP | disclosed |
| EP-0022183-B1 | DERIVATIVES OF CYCLOHEXYLBIPHENYL, PROCESS FOR THEIR PREPARATION, DIELECTRICS CONTAINING THEM, AND ELECTRON OPTICAL INDICATING ELEMENTS | MERCK PATENT GmbH (DE) | 1982-06-23 | — | — | EP | disclosed |
| US-4330426-A | Cyclohexylbiphenyls, their preparation and use in dielectrics and electrooptical display elements | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1982-05-18 | — | — | US | disclosed |
| EP-0022183-A2 | Derivatives of cyclohexylbiphenyl, process for their preparation, dielectrics containing them, and electron optical indicating elements | MERCK PATENT GmbH (DE) | 1981-01-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260040821-A1 | LAMINATE, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE COMPRISING THE LAMINATE | LEF1, L1CAM, LIN28A | CYP2C9 2645/4885ALDH1A1 1911/4885LMNA 621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.